Last reviewed · How we verify
Iron Sucrose Solution for Injection
At a glance
| Generic name | Iron Sucrose Solution for Injection |
|---|---|
| Sponsor | Assiut University |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- A Study to Evaluate Ferumoxytol for the Treatment of Iron Deficiency Anemia (IDA) in Pediatric Subjects (PHASE3)
- A Study to Evaluate the Safety (Compared to Iron Sucrose), Efficacy and Pharmacokinetics of Ferumoxytol for the Treatment of Iron Deficiency Anemia (IDA) in Pediatric Subjects With Chronic Kidney Disease (CKD) (PHASE3)
- Iron Administration Via Colonic TET Combined With WMT for ID (PHASE2)
- To Assess the Impact of Ferric Carboxymaltose Compared With Iron Sucrose in Chinese Subjects on Correcting Iron Deficiency Anaemia (PHASE3)
- Bioequivalence Study Assessing Iron Sucrose or Venofer® in Healthy Adult Subjects (PHASE1)
- Evaluation on Performance and Oxydative Stress in Patient With Iron deficIency and Stable Heart Failure Study (PHASE4)
- Predictors of Response to Iron and Erythropoietin Stimulating Agents (PHASE4)
- Fetal Vascular Hemodynamic Changes in Iron Deficiency Anemia
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |